LRMR NASDAQ
Larimar Therapeutics, Inc.
1W: -8.2%
1M: -21.7%
3M: +20.2%
YTD: +2.9%
1Y: +73.3%
3Y: -2.2%
5Y: -73.3%
$3.45
-0.12 (-3.36%)
Weekly Expected Move ±8.1%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-166M
Net Income
-74.3% YoY
$-131M
Free Cash Flow
-50.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-132.9%
ROA-95.9%
ROIC249.0%
Valuation
P/E-1.8
P/B1.9
EV/EBITDA-1.5
Leverage
Debt/Equity0.05
Current Ratio2.19
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-4.01
Beneish M0.00